Strategies to genetically engineer T cells for cancer immunotherapy
Immunotherapy is one of the most promising and innovative approaches to treat cancer, viral infections, and other immune modulated diseases. Adoptive immunotherapy using gene modified T cells is an exciting and rapidly evolving field. Exploiting knowledge of basic T cell biology and immune cell receptor function has fostered innovative approaches to modify immune cell function. Highly translatable clinical technologies have been developed to redirect T cell specificity by introducing designed receptors. The ability to engineer T cells to manifest desired phenotypes and functions is now a thrilling reality. In this review, we focus on outlining different varieties of genetically engineered T cells, their respective advantages and disadvantages as tools for immunotherapy, and their promise and drawbacks in the clinic.
Cancer Immunology, Immunotherapy